Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $43.9500 (2.57%) ($42.8500 - $44.5000) on Tue. Jun. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 35 | Latest Price | $43.9500(2.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.98% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-11%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | 2.6% | | | |
|
Resistance Level | $47.91 | 5 Day Moving Average | $44.05(-0.23%) | 10 Day Moving Average | $46.58(-5.65%) | 20 Day Moving Average | $47.91(-8.27%) | To recent high | -14.6% | To recent low | 25% | Market Cap | $3.266b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |